Only a single plasma sample had a KRAS Mx mutation which was also seen in the tumor; the NRAS Q61 mutation was seen in 3 cases, both in cfDNA and tumor DNA; and no mutations in NRAS G12/G13 were detected in any of these 17 cfDNA samples or their matched tumors (Table 3). Here, KRAS is linked to neoplasm.